Orbimed Advisors LLC Spero Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$5.27 - $10.41 $693,811 - $1.37 Million	-131,653 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$9.46 - $12.16 $85,669 - $110,120	-9,056 Reduced 6.44%	131,653 $1.27 Million
Q3 2019 Nov 14, 2019	SELL	$9.01 - $12.55 $3.3 Million - $4.6 Million	-366,762 Reduced 72.27%	140,709 $1.49 Million
Q1 2019 May 15, 2019	BUY	$6.26 - $13.31 $3.18 Million - $6.75 Million	507,471 New	507,471 $6.5 Million

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $35.1M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.